Welcure Drugs and Pharmaceuticals has announced its plan to establish an agro-pharma research laboratory with an investment of INR 70-80 crore.  

The lab would be used to research, validate, and scale processes for the conversion of agricultural/botanical inputs into pharma-grade products aimed at public health and societal wellbeing, the company informed in an exchange filing.

“Facilities and processes will be designed to align with applicable cGMP standards and the US FDA’s Botanical Drug Development guidance (as relevant), in order to enable participation in broader international markets for botanical/ayurvedic products, subject to all necessary approvals,” it said.

The estimated project cost will include laboratory infrastructure, pilot lines, analytics and quality systems, Welcure noted.  

Welcure also plans to raise up to INR 80 crore by way of qualified institutional placement (QIP), in one or more tranches, to fund the project and for permitted general corporate purposes.

The site, timeline and commissioning plan for the laboratory project will be finalised after approval from the board, it said, adding that the company's board will meet on August 28 to consider the QIP issue.

“A meeting of the board of directors will be held on Thursday, 28 August 2025, inter alia, to consider and, if deemed appropriate, approve the aforesaid fund-raising by QIP, including approving enabling resolutions, issue structure, and seeking shareholders’ approval as may be required,” it said.